Government grant programs that help fund R&D activities at medtech start-ups are at risk of vanishing this year, trade group AdvaMed said in an 18 May grassroots training conference call.
The group is nudging its members to lobby Congress to renew the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs before they expire on 30 September....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?